Pharmacology, Toxicology and Pharmaceutical Science
Angiotensin Receptor Antagonist
100%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Diabetes Mellitus
100%
Clinical Trial
25%
Human Study
25%
Pharmacotherapy
25%
Prospective Study
25%
Placebo
25%
Prevalence
25%
Renin
25%
Angiotensin
25%
Comorbidity
25%
Cardiovascular Disease
25%
Maturity Onset Diabetes of the Young
25%
Medicine and Dentistry
Diabetes
100%
Diabetes Mellitus
100%
ACE Inhibitor
100%
Angiotensin Receptor Antagonist
100%
Cardiovascular Disease
14%
Drug Therapy
14%
Lifestyle Modification
14%
Renin Angiotensin Aldosterone System
14%
Clinical Trial
14%
Maturity Onset Diabetes of the Young
14%
Prevalence
14%
Prospective Study
14%
Human Study
14%
Glucose Homeostasis
14%
Placebo
14%
Comorbidity
14%
Nursing and Health Professions
Dipeptidyl Carboxypeptidase Inhibitor
100%
Angiotensin Receptor Antagonist
100%
Diabetes Mellitus
100%
Lifestyle Modification
25%
Drug Therapy
25%
Prevalence
25%
Placebo
25%
Cardiovascular Disease
25%
Angiotensin
25%
Renin
25%
Comorbidity
25%
Maturity Onset Diabetes of the Young
25%
Neuroscience
Angiotensin Receptor
100%
Receptor Antagonist
100%
Diabetes Mellitus
100%
ACE Inhibitor
100%
Angiotensin
25%
Renin
25%
Placebo
25%
Comorbidity
25%
Drug Therapy
25%